MRC1 and cancer: Variant classification is especially significant in LS given the need to report incidental findings in MMR genes, which are included in the ACMG secondary findings list [12], and given the latest ASCO recommendation to include the MMR genes whenever germline multigene panel testing is ordered for patients with any cancer, not just LS-associated cancer types [13].